ClinicalTrials.Veeva

Menu

Endoscopic Sphincterotomy vs. Balloon Dilation for Assessment of Pancreatitis

H

Helios Albert-Schweitzer-Klinik Northeim

Status

Unknown

Conditions

Pancreatitis

Treatments

Procedure: balloon dilatation for 3 minutes
Procedure: endoscopic sphincterotomy
Procedure: balloon dilatation for 6 minutes

Study type

Interventional

Funder types

Other

Identifiers

NCT02346448
HELIOS 4/8/14

Details and patient eligibility

About

One of the major elements of successful endoscopic retrograde cholangiopancreatography ( ERCP) is the timely and uncomplicated cannulation of the common bile duct (CBD) . Various factors may adversely affect the cannulation procedure of the CBD leading to complications (acute pancreatitis after ERCP, perforation of the duodenum , bleeding ). Endoscopic sphincterotomy is frequently required for interventional procedures (eg stone extraction). During sphincterotomy, incision of the orifice of the papilla will be performed by using a sphincterotome. Complications due to sphincterotomy are known: Bleeding, increased rates of acute pancreatitis, small bowel perforation and scarring with consecutive stenosis of the papilla. As an alternative to sphincterotomy, balloon dilatation using balloon catheters can be performed. As a result, bleeding complications and scarring as late effects might be prevented. Current data is limited in terms of the risk of acute pancreatitis after ERCP when using a balloon catheter.

This study aims to evaluate the incidence of acute pancreatitis and other complications after ERCP. Balloon dilatation of the papilla will be prospectively compared with endoscopic sphincterotomy in a randomized multicenter setting.

Enrollment

600 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • independent indication for ERCP
  • age ≥ 18 years
  • patient is able to understand informed consent

Exclusion criteria

  • S/p sphincterotomy
  • pancreatic or CBD-stent in situ
  • pregnant patient
  • known chronic pancreatitis
  • acute pancreatitis prior to intervention

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Factorial Assignment

Masking

Single Blind

600 participants in 3 patient groups

endoscopic sphincterotomy
Active Comparator group
Description:
performing endoscopic sphincterotomy of papilla of Vater during ERCP Device: standard sphincterotome
Treatment:
Procedure: endoscopic sphincterotomy
balloon dilatation for 3 minutes
Active Comparator group
Description:
Balloon dilatation of papilla of Vater for 3 minutes during ERCP using 10mm balloon Device: standard dilation balloon catheter (10mm size)
Treatment:
Procedure: balloon dilatation for 3 minutes
balloon dilatation for 6 minutes
Active Comparator group
Description:
Balloon dilatation of papilla of Vater for 6 minutes during ERCP using 10mm balloon Device: standard dilation balloon catheter (10 mm size)
Treatment:
Procedure: balloon dilatation for 6 minutes

Trial contacts and locations

3

Loading...

Central trial contact

Tobias Meister, PDDr.med.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems